Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if there is an excess risk of acute kidney injury
(AKI) with Serotonin-norepinephrine reuptake inhibitors (SNRIs) as compared to Selective
serotonin reuptake inhibitors (SSRIs), two classes of medication used for the treatment of
depression.
Details
Lead Sponsor:
Canadian Network for Observational Drug Effect Studies, CNODES
Collaborators:
Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Network, Canada